Kilitch Drugs (India) (NSE:KILITCH) Cyclically Adjusted Book per Share: ₹64.25 (As of Mar. 2026)


NSE:KILITCH Kilitch Drugs (India) Ltd NSE:KILITCH
84 GF Score
Price ₹183.12
GF Value ₹226.20
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Kilitch Drugs (India) Cyclically Adjusted Book per Share?

Kilitch Drugs (India) NSE:KILITCH -1.25% 84 Cyclically Adjusted Book per Share is ₹64.25 as of Mar. 2026. GuruFocus rates NSE:KILITCH with a GF Score™ of 84/100 and a GF Value™ of ₹226.20 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kilitch Drugs (India)'s adjusted book value per share for the three months ended in Mar. 2026 was ₹79.988. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹64.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Kilitch Drugs (India)'s average Cyclically Adjusted Book Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-09), Kilitch Drugs (India)'s current stock price is ₹183.12. Kilitch Drugs (India)'s Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹64.25. Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio of today is 2.85.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kilitch Drugs (India) was 3.57. The lowest was 1.95. And the median was 2.62.


Kilitch Drugs (India)  (NSE:KILITCH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=183.12/64.25
=2.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kilitch Drugs (India) was 3.57. The lowest was 1.95. And the median was 2.62.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kilitch Drugs (India) Cyclically Adjusted Book per Share Related Terms


Kilitch Drugs (India) Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Kilitch Drugs (India)'s Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kilitch Drugs (India) Cyclically Adjusted Book per Share Chart

Kilitch Drugs (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 63.75 64.25

Kilitch Drugs (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.75 0.00 65.93 0.00 64.25

NSE:KILITCH vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India) Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio falls into.


NSE:KILITCH
84GF Score
Kilitch Drugs (India) Ltd NSE:KILITCH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kilitch Drugs (India) Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kilitch Drugs (India)'s adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=79.988/164.2724*164.2724
=79.988

Current CPI (Mar. 2026) = 164.2724.

Kilitch Drugs (India) Quarterly Data

Book Value per Share CPI Adj_Book
201209 86.858 82.244 173.488
201212 0.000 83.774 0.000
201303 44.025 85.687 84.401
201403 44.460 91.425 79.886
201503 44.331 97.163 74.950
201603 39.844 102.518 63.845
201703 37.423 105.196 58.439
201803 39.919 109.786 59.730
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 38.575 118.202 53.610
201906 0.000 120.880 0.000
201909 38.290 123.175 51.065
201912 0.000 126.235 0.000
202003 37.489 124.705 49.384
202006 0.000 127.000 0.000
202009 38.553 130.118 48.673
202012 0.000 130.889 0.000
202103 40.147 131.771 50.049
202106 0.000 134.084 0.000
202109 41.959 135.847 50.739
202112 0.000 138.161 0.000
202203 43.676 138.822 51.683
202206 0.000 142.347 0.000
202209 45.451 144.661 51.613
202212 0.000 145.763 0.000
202303 47.603 146.865 53.245
202306 0.000 150.280 0.000
202309 50.937 151.492 55.234
202312 0.000 152.924 0.000
202403 53.636 153.035 57.575
202406 0.000 155.789 0.000
202409 57.600 157.882 59.931
202412 0.000 158.323 0.000
202503 61.558 157.552 64.184
202506 0.000 159.755 0.000
202509 75.985 162.289 76.914
202512 0.000 163.281 0.000
202603 79.988 164.272 79.988

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹64.25 mean?
Kilitch Drugs (India) (NSE:KILITCH) has a Cyclically Adjusted Book per Share of ₹64.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kilitch Drugs (India) and its competitors.
Is Kilitch Drugs (India)'s Cyclically Adjusted Book per Share too high?
Kilitch Drugs (India)'s current Cyclically Adjusted Book per Share is ₹64.25. Overall, Kilitch Drugs (India) has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kilitch Drugs (India)'s Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Kilitch Drugs (India)'s Cyclically Adjusted Book per Share of ₹64.25 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Kilitch Drugs (India) and its competitors. Kilitch Drugs (India)'s current Cyclically Adjusted Book per Share is ₹64.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kilitch Drugs (India) stock overvalued right now?
Based on GuruFocus' analysis, Kilitch Drugs (India) (NSE:KILITCH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹226.20, compared to a current price of ₹183.12 — trading 19% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹64.25. Kilitch Drugs (India)'s overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Kilitch Drugs (India) (NSE:KILITCH), the current Cyclically Adjusted Book per Share is ₹64.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kilitch Drugs (India) (NSE:KILITCH) Overvalued in 2026?

Based on GuruFocus' analysis, Kilitch Drugs (India) stock appears to be undervalued. The current stock price of ₹183.12 is trading 19% below its estimated GF Value™ of ₹226.20. GuruFocus considers Kilitch Drugs (India) to be Modestly Undervalued.

Key valuation signals for NSE:KILITCH:

  • Cyclically Adjusted Book per Share: ₹64.25
  • GF Value™: ₹226.20 vs. price of ₹183.12 (19% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the NSE:KILITCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kilitch Drugs (India) Business Description

Other Exchanges 524500:India
Address Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in operation and management of Pharmaceutical Products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, and HPURE. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.
84GF Score

Get the complete analysis for NSE:KILITCH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹183.12
Price
₹226.20
GF Value